Points to Consider From the ESTP Pathology 2.0 Working Group: Overview on Spatial Omics Technologies Supporting Drug Discovery and Development.

Saved in:
Bibliographic Details
Title: Points to Consider From the ESTP Pathology 2.0 Working Group: Overview on Spatial Omics Technologies Supporting Drug Discovery and Development.
Authors: Hahn K; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Amberg B; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland., Monné Rodriguez JM; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Verslegers M; Johnson & Johnson, Beerse, Belgium., Kang B; Novartis Biomedical Research, Cambridge, Massachusetts, USA., Wils H; Johnson & Johnson, Beerse, Belgium., Saravanan C; Novartis Biomedical Research, Cambridge, Massachusetts, USA., Bangari DS; Sanofi Global Discovery Pathology, Cambridge, Massachusetts, USA., Long SY; Novartis Biomedical Research, Cambridge, Massachusetts, USA., Youssef SA; Johnson & Johnson, Beerse, Belgium., Pesti B; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Schaffenrath J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Valdeolivas A; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Kumpesa N; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Galván JA; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Richardson M; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Giroud N; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Kunz L; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Veiga IB; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Bscheider M; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Cramer P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Jiang S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Kreutzer R; AnaPath Services GmbH, Liestal, Switzerland., Vezzali E; Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland., Yun SW; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Rottenberg S; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.; Bern Center for Precision Medicine and Cancer Therapy Resistance Cluster, Department for BioMedical Research, University of Bern, Bern, Switzerland., Jacobsen B; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Source: Toxicologic pathology [Toxicol Pathol] 2025 Jan; Vol. 53 (1), pp. 107-129. Date of Electronic Publication: 2025 Feb 10.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 7905907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-1601 (Electronic) Linking ISSN: 01926233 NLM ISO Abbreviation: Toxicol Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1533-1601
DOI:10.1177/01926233241311258